Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsBertrand Routy, Laurence Zitvogel, Emmanuelle Le Chatelier et al.|Science|2017Cited by 5.4k
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaRobert J. Motzer, Bernard Escudier|New England Journal of Medicine|2018Cited by 4.6k
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Vincent Cattoir, Romain Daillère et al.|Science|2020Cited by 382
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBernard Escudier, Vesa Kataja, Tim Eisen et al.|Annals of Oncology|2012Cited by 275
Axitinib for the Management of Metastatic Renal Cell CarcinomaBernard Escudier, Martin Gore|Drugs in R&D|2011Cited by 147